Sampre Nutritions Limited (SAMPRE.BO)
INR 70.98
(1.28%)
INR 70.98
(1.28%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | 39.52 Million | 8.78 Million | 24.08 Million | -1.77 Million | 25.78 Million |
| Net Income | 4.87 Million | 4.17 Million | 3.72 Million | 1.08 Million | 3.35 Million |
| Depreciation & Amortization | 18.32 Million | 18.21 Million | 16.34 Million | 18.08 Million | 14.92 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -4.81 Million | -28.75 Million | -9.45 Million | -26.29 Million | 13.95 Million |
| Other non-cash items | 18.97 Million | 17.75 Million | 16.68 Million | 7.41 Million | -6.44 Million |
| Investing Cash Flow | -36.99 Million | -43.16 Million | -7.64 Million | -8.99 Million | -12.58 Million |
| Investments in PPE | -37.08 Million | -44.06 Million | -13.01 Million | -23.55 Million | -13.75 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 96 Thousand | 897 Thousand | 5.37 Million | 14.56 Million | 1.17 Million |
| Financing Cash Flow | -945 Thousand | 34.81 Million | -16.58 Million | 3.26 Million | -8.16 Million |
| Debt repayment | -7.29 Million | -44.62 Million | -131 Thousand | -10.68 Million | -7.22 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 10.8 Million | 97.2 Million | - | - | - |
| Other Financing Activities | 11.56 Million | 55.01 Million | 1000.00 | -4.94 Million | -1000.00 |
| Accounts receivables | - | - | - | - | - |
| Accounts payables | - | - | - | - | - |
| Inventory | -5.44 Million | 529 Thousand | 1.99 Million | -2.56 Million | -11.07 Million |
| Other working capital | 18.43 Million | -29.58 Million | -1.13 Million | -24.48 Million | 25.02 Million |
| Cash at beginning of period | 1.25 Million | 825 Thousand | 973 Thousand | 8.47 Million | 3.43 Million |
| Cash at end of period | 2.84 Million | 1.25 Million | 825 Thousand | 973 Thousand | 8.47 Million |
| Capital Expenditure | -37.08 Million | -44.06 Million | -13.01 Million | -23.55 Million | -13.75 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | 1.58 Million | 434 Thousand | -148 Thousand | -7.5 Million | 5.03 Million |
| Free Cash Flow | 2.43 Million | -35.27 Million | 11.06 Million | -25.32 Million | 12.02 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 989 Thousand | 4.87 Million | 4.71 Million | 1.98 Million | 3.56 Million | -7.94 Million |
| Depreciation & Amortization | - | 18.32 Million | - | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -4.81 Million | - | - | - | - |
| Other non-cash items | -989 Thousand | 18.97 Million | -4.71 Million | -1.98 Million | -3.56 Million | 7.94 Million |
| Investing Cash Flow | - | -36.99 Million | - | - | - | - |
| Investments in PPE | - | -37.08 Million | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 96 Thousand | - | - | - | - |
| Financing Cash Flow | - | -945 Thousand | - | - | - | - |
| Debt repayment | - | -7.29 Million | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 10.8 Million | - | - | - | - |
| Other Financing Activities | - | 11.56 Million | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | -5.44 Million | - | - | - | - |
| Other working capital | - | 18.43 Million | - | - | - | - |
| Cash at beginning of period | - | 1.25 Million | - | - | - | - |
| Cash at end of period | - | 2.84 Million | - | - | - | - |
| Capital Expenditure | - | -37.08 Million | - | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | 1.58 Million | - | - | - | - |
| Free Cash Flow | - | 2.43 Million | - | - | - | - |
0QN2
BAC
0HS4
TRICOMFRU
ACTG
7420